Product NDC: | 51672-1317 |
Proprietary Name: | Betamethasone Dipropionate |
Non Proprietary Name: | Betamethasone Dipropionate |
Active Ingredient(s): | .5 mg/g & nbsp; Betamethasone Dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT, AUGMENTED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1317 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076753 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041012 |
Package NDC: | 51672-1317-3 |
Package Description: | 1 TUBE in 1 CARTON (51672-1317-3) > 50 g in 1 TUBE |
NDC Code | 51672-1317-3 |
Proprietary Name | Betamethasone Dipropionate |
Package Description | 1 TUBE in 1 CARTON (51672-1317-3) > 50 g in 1 TUBE |
Product NDC | 51672-1317 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betamethasone Dipropionate |
Dosage Form Name | OINTMENT, AUGMENTED |
Route Name | TOPICAL |
Start Marketing Date | 20041012 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | BETAMETHASONE DIPROPIONATE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |